We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
Cap. Flow
+$313M
Cap. Flow %
6.14%
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$115M
2
BHC icon
Bausch Health
BHC
+$84M
3
BKD icon
Brookdale Senior Living
BKD
+$72M
4
ABT icon
Abbott
ABT
+$56.3M
5
AET
Aetna Inc
AET
+$56.2M

Top Sells

Rank Stock Value
1
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$160M
2
PRGO icon
Perrigo
PRGO
+$122M
3
ENDP
Endo International plc
ENDP
+$115M
4
AMGN icon
Amgen
AMGN
+$82M
5
ESRX
Express Scripts Holding Company
ESRX
+$36.6M

Sector Composition

Rank Sector Weight
1 Healthcare 53.68%
2 Consumer Discretionary 6.01%
3 Consumer Staples 4.52%
4 Utilities 3.94%
5 Industrials 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan Inc
AGN
$294M 5.77%
2,648,000
-133,620
-5% -$12.8M
CAH icon
2
Cardinal Health
CAH
$54.5B
$285M 5.6%
4,267,168
-262,599
-6% -$16M
AGN
3
DELISTED
Allergan plc
AGN
$246M 4.82%
1,462,461
+738,668
+102% +$115M
PRGO icon
4
Perrigo
PRGO
$1.45B
$123M 2.42%
804,254
-843,366
-51% -$122M
BKD icon
5
Brookdale Senior Living
BKD
$3.57B
$109M 2.15%
4,022,895
+2,596,835
+182% +$72M
SLXP
6
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$93.5M 1.84%
1,040,069
+490,069
+89% +$39.1M
BHC icon
7
Bausch Health
BHC
$1.68B
$90M 1.77%
+766,970
New +$84M
GILD icon
8
Gilead Sciences
GILD
$166B
$83.4M 1.64%
1,109,913
-304,196
-22% -$21.2M
HCA icon
9
HCA Healthcare
HCA
$92.3B
$82.3M 1.62%
1,724,820
+297,421
+21% +$13.7M
ABT icon
10
Abbott
ABT
$191B
$71.1M 1.4%
1,855,467
+1,528,175
+467% +$56.3M
PCRX icon
11
Pacira BioSciences
PCRX
$1.04B
$65.5M 1.29%
1,140,000
+155,000
+16% +$8.15M
AET
12
DELISTED
Aetna Inc
AET
$65.3M 1.28%
951,617
+861,645
+958% +$56.2M
MNTA
13
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$64M 1.26%
3,620,000
+2,820,000
+353% +$47.4M
WCG
14
DELISTED
Wellcare Health Plans, Inc.
WCG
$64M 1.26%
908,594
+94,500
+12% +$6.6M
AVP
15
DELISTED
Avon Products, Inc.
AVP
$61.2M 1.2%
3,556,373
-840,885
-19% -$15.7M
GRFS
16
Grifois
GRFS
$5.55B
$57M 1.12%
3,156,624
+635,506
+25% +$10.2M
ICPT
17
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$52.3M 1.03%
766,531
-484
-0.1% -$28K
ENDP
18
DELISTED
Endo International plc
ENDP
$51.7M 1.02%
767,019
-2,018,842
-72% -$115M
DS
19
DELISTED
Drive Shack Inc.
DS
$43.1M 0.85%
8,295,805
+2,214,409
+36% +$11.1M
ELOS
20
DELISTED
Syneron Medical Ltd
ELOS
$41.9M 0.82%
3,405,000
– –
HR icon
21
Healthcare Realty
HR
$7.56B
$37.1M 0.73%
1,886,974
-261,180
-12% -$5.54M
MED icon
22
Medifast
MED
$107M
$35.3M 0.69%
1,350,000
– –
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
$33.8M 0.66%
561,184
+223,125
+66% +$12.1M
RPRX
24
DELISTED
Repros Therapeutics Inc.
RPRX
$33.7M 0.66%
1,840,699
+15,699
+0.9% +$296K
SPY icon
25
State Street SPDR S&P 500 ETF Trust
SPY
$775B
$33.7M 0.66%
182,320
-99,361
-35% -$17.6M
1
2 3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Visium Asset Management deployed $313M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.

  • Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
  • Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
  • Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
  • Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
  • Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
  • Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
  • Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.

Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.